Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Dr. Oliver Medvedik, LEAF vice president and Director of the Maurice Kanbar Center for Biomedical Engineering at the Cooper Union, chaired a panel with a focus on starting up biotech companies and dealing with the challenges inherent to launching a company in this industry.

In this panel, Dr. Oliver Medvedik, Dr. Michael West of AgeX Therapeutics, Kelsey Moody of Ichor Therapeutics, Stephen Hilbert of Oisin Biotechnologies, Dr. Sudhir Paul of Covalent Bioscience, Bobby Brooke of Intervene Immune, and Reason of Repair Biotechnologies/Fight Aging! discuss their experiences in the creation of successful startup companies in the aging research sector.

Here, they touch upon the huge gap between the lab and the commercial world and the way that promising ideas in the lab can often fail early and vanish into the valley of death, discuss intellectual property (IP) and its place in developing biotechnology, and discuss other pitfalls of creating a new rejuvenation biotech company.

We were aiming for our conference to offer the latest aging research while providing solid advice, guidance, and insights from the worlds of biotech startups and investment. We are confident that we achieved this and hope that you will enjoy this informative panel.

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic as well as attending various medical industry conferences. In 2019 he was listed in the top 100 journalists covering biomedicine and longevity research in the industry report – Top-100 Journalists covering advanced biomedicine and longevity created by the Aging Analytics Agency. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, and, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project. In 2015 he led the Major Mouse Testing Program (MMTP) for the International Longevity Alliance and in 2016 helped the team of the SENS Research Foundation to reach their goal for the OncoSENS campaign for cancer research.
Write a comment:


Your email address will not be published.

Privacy Policy / Terms Of Use

       Powered by MMD